Your session is about to expire
← Back to Search
Acupressure for Rheumatoid Arthritis
Study Summary
This trial is testing if acupressure is a good option for people with rheumatoid arthritis.
- Rheumatoid Arthritis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are taking the medication called Leflunomide (brand name Arava).You have difficulty seeing or hearing that would make it hard for you to take part in the study.You have a serious mental health condition or a history of substance abuse problems.You are taking hydroxychloroquine (Plaquenil).You are currently taking a medication called baricitinib (brand name Olumiant).You are taking very strong pain medications, such as opioids, in high doses (more than 100 oral morphine equivalents).You are currently taking a medication called sulfasalazine (brand name Azulfadine).You are currently taking a medication called abatacept (Orencia).You have an allergy or known sensitivity to the medication tocilizumab (brand name Actemra).You are currently taking a medication called tumor necrosis factor inhibitor (TNFi).You are taking Etanercept (Enbrel) medication.You are taking a medication called a Janus kinase inhibitor (JAKi).You are taking a medication called tofacitinib (Xeljanz).You are taking the medication called Upadacitinib (Rinvoq).
- Group 1: Acupressure
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the eligibility criterion for this investigation restricted to individuals aged eighty or younger?
"This medical trial accepts participants aged 25 and over, up to a maximum of 75 years."
Does my profile fulfill the requirements to join this experiment?
"To qualify for this clinical trial, potential participants should be between 25 and 75 years old, with a diagnosis of rheumatoid arthritis. In total, the research team is looking to recruit 30 individuals."
How many participants have volunteered for this clinical research?
"Affirmative. Evidenced by the information present on clinicaltrials.gov, this particular trial is still actively recruiting participants. The study was first made available to prospective patients on September 15th 2022 and has since been updated as of October 30th 2022; thus far, thirty individuals are needed from a single medical site for enrollment."
Are there any open enrollments for this clinical trial presently?
"Indeed, data hosted on clinicaltrials.gov illustrates that this medical study is currently recruiting participants. This trial was initially advertised on September 15th 2022 and underwent its latest update 30 days later. The research effort requires the enrollment of 30 patients from a single site."
Share this study with friends
Copy Link
Messenger